跳至主要内容
临床试验/IRCT20220514054845N1
IRCT20220514054845N1招募中3 期

Evaluating the efficacy of herbal preparation Ashwagandha (Withania somnifera (L.) Dunal) on disease severity in patients with mild to moderate Alzheimer's disease: A triple-blind clinical trial

Kerman University of Medical Sciences0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
50 years 至 85 years(—)
性别
All

入选标准

  • Having informed consent for study participation
  • Having a CDR score less than or equal to 2
  • Having an ADAS-COG score higher than or equal to 12
  • Ability to participate in the study

排除标准

  • Inability to participate in the study
  • Inability to continue treatment
  • Presence of heart disease
  • Substance abuse and alcohol addiction
  • Taking anticoagulant drugs

研究者

相似试验